Why This Matters for Your Career
Ferring Pharmaceuticals is hiring 10 roles related to this product
DESMOPRESSIN ACETATE (desmopressin acetate) by Ferring Pharmaceuticals is acetate's primary pharmacodynamic action involves its binding to vasopressin 2 (v2) receptors. Approved for nephrogenic diabetes insipidus, central diabetes insipidus. First approved in 2006.
acetate's primary pharmacodynamic action involves its binding to vasopressin 2 (V2) receptors. V2 receptors are primarily located in the distal convoluted tubule and collecting ducts of the nephron in the kidneys. These receptors play a crucial role in regulating water reabsorption and urine…
Worked on DESMOPRESSIN ACETATE at Ferring Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Desmopressin Acetate 0.2 mg Tablets, Fasting
Ferring Pharmaceuticals is hiring 10 roles related to this product